Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia.

scientific article published on 3 August 2006

Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10038-006-0029-X
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s10038-006-0029-x
P698PubMed publication ID16897188
P5875ResearchGate publication ID6890357

P50authorCS ChimQ64761563
P2093author name stringR Liang
K F Wong
T K Fung
J S Lau
P2860cites workHypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational statusQ28143274
The INK4a/ARF network in tumour suppressionQ28190064
A gene hypermethylation profile of human cancerQ28213253
Hypermethylation of gene promoters in hematological neoplasiaQ28216777
The biochemistry of apoptosisQ29547741
Gene silencing in cancer in association with promoter hypermethylationQ29617274
Inactivation of the apoptosis effector Apaf-1 in malignant melanomaQ31984891
Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia.Q34327110
TP53 in hematological cancer: low incidence of mutations with significant clinical relevanceQ35078753
Biology and treatment of chronic lymphocytic leukemiaQ35591429
Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patientsQ35770277
Intrinsic tumour suppressionQ35953133
SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathwayQ38344554
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).Q40420609
Methylation profiling in multiple myeloma.Q40514855
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformationQ40833586
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cellsQ40854057
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies.Q40949835
Cytogenetics in chronic lymphocytic leukemia.Q41712556
Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.Q44243321
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patientsQ44791847
Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemiaQ46766310
Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phaseQ47445275
Cancer statistics, 1997.Q50980276
Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.Q54755048
The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 casesQ71997303
Expression of p16INK4A and p14ARF in hematological malignanciesQ73171012
Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significanceQ73703062
Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significanceQ74046091
Cytogenetic abnormalities in chronic B-cell lymphoproliferative disorders in Chinese patientsQ77747520
Infrequent Wnt inhibitory factor-1 (Wif-1) methylation in chronic lymphocytic leukemiaQ82329418
P433issue9
P921main subjectleukemiaQ29496
lymphocyteQ715347
hypermethylationQ106875739
P304page(s)832-838
P577publication date2006-08-03
P1433published inJournal of Human GeneticsQ6295302
P1476titleFrequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia
P478volume51

Reverse relations

cites work (P2860)
Q81079624Aberrant gene promoter methylation in plasma cell dyscrasias
Q46060620CpG island methylation patterns in chronic lymphocytic leukemia
Q38060723DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.
Q38343779DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Q33285707Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing
Q36287377Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
Q37424922Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway
Q37616347Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Q36621405Epigenetic inactivation of the MIR129-2 in hematological malignancies.
Q31008825Epigenetic inactivation of the miR-124-1 in haematological malignancies
Q39745821Epigenetic inactivation of the miR-34a in hematological malignancies
Q37696142Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Q36688994Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Q38889464Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
Q46864071Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin lymphoma.
Q36981741Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes
Q24646541Regulation of death-associated protein kinase. Stabilization by HSP90 heterocomplexes
Q34413764Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.

Search more.